Daniel Schwartz
Overview
Explore the profile of Daniel Schwartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
4066
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pruitt P, Yu K, Lahna D, Schwartz D, Peltier S, Silbert L, et al.
Soc Cogn Affect Neurosci
. 2025 Feb;
20(1).
PMID: 39891390
Despite having a meaningful impact on the quality of life, emotional well-being is often understudied in older adults in favor of cognitive performance, particularly when examining its association with neurobiological...
2.
Schwartz D, Torres-Ulloa I, Corvalan C
Prev Med
. 2024 Aug;
187:108087.
PMID: 39097006
Objective: The World Health Organization recommends using health-risk warnings on alcoholic beverages. This study examines the impact of separate or combined warning labels for at-risk groups and the general population...
3.
Rigatto C, Collister D, Granger-Vallee A, Girard L, Hingwala J, Karaboyas A, et al.
Can J Kidney Health Dis
. 2024 Apr;
11:20543581241238808.
PMID: 38680970
Purpose Of Review: Chronic kidney disease (CKD)-associated pruritus is a common, persistent, and distressing itch experienced by patients across the CKD spectrum. Although the disorder is associated with adverse outcomes...
4.
Tsalatsanis A, Dismuke-Greer C, Kumar A, Hoffman J, Monden K, Magalang U, et al.
J Head Trauma Rehabil
. 2024 Apr;
39(6):E498-E506.
PMID: 38652666
Objective: To assess the cost-effectiveness of alternative approaches to diagnose and treat obstructive sleep apnea (OSA) in patients with traumatic brain injury (TBI) during inpatient rehabilitation. Setting: Data collected during...
5.
Wongsawaeng D, Schwartz D, Li X, Muldoon L, Stoller J, Stateler C, et al.
Neuroradiol J
. 2024 Mar;
37(4):473-482.
PMID: 38544404
Purpose: To compare DSC-MRI using Gadolinium (GBCA) and Ferumoxytol (FBCA) in high-grade glioma at 3T and 7T MRI field strengths. We hypothesized that using FBCA at 7T would enhance the...
6.
Karvelas N, Oh B, Wang E, Cobigo Y, Tsuei T, Fitzsimons S, et al.
Brain Commun
. 2024 Mar;
6(2):fcae071.
PMID: 38495305
Enlarged perivascular spaces have been previously reported in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, but their significance and pathophysiology remains unclear. We investigated associations of white matter...
7.
Jamshidi M, Ventimiglia T, Sudres P, Zhang C, Lesage F, Rooney W, et al.
Microcirculation
. 2024 Jan;
31(3):e12845.
PMID: 38265175
Objective: The role of cerebral microvasculature in cognitive dysfunction can be investigated by identifying the impact of blood flow on cortical tissue oxygenation. In this paper, the impact of capillary...
8.
Polley M, Schwartz D, Karrison T, Dignam J
Neuro Oncol
. 2024 Jan;
26(5):796-810.
PMID: 38254183
Background: Randomized controlled trials have been the gold standard for evaluating medical treatments for many decades but they are often criticized for requiring large sample sizes. Given the urgent need...
9.
Kersch C, Muldoon L, Claunch C, Fu R, Schwartz D, Cha S, et al.
Neuroradiol J
. 2023 Jun;
:19714009231163560.
PMID: 37306690
Rationale And Objective: Poor clinical outcomes for patients with glioblastoma are in part due to dysfunction of the tumor-immune microenvironment. An imaging approach able to characterize immune microenvironmental signatures could...
10.
Jimenez-Zepeda V, Bril V, Lemieux-Blanchard E, Royal V, McCurdy A, Schwartz D, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Jan;
23(3):194-202.
PMID: 36653205
Amyloidosis is a rare protein misfolding disease caused by the accumulation of amyloid fibrils in various tissues and organs. There are different subtypes of amyloidosis, with light chain (AL) amyloidosis...